NCT02022943

Brief Summary

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500,000

participants targeted

Target at P75+ for all trials

Timeline
44mo left

Started May 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
May 2012Jan 2030

Study Start

First participant enrolled

May 1, 2012

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 23, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 30, 2013

Completed
16 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

17.7 years

First QC Date

December 23, 2013

Last Update Submit

December 8, 2025

Conditions

Keywords

Alzheimer'sprevention

Outcome Measures

Primary Outcomes (1)

  • Number of individuals enrolled into Alzheimer's prevention studies

    16 years

Secondary Outcomes (1)

  • Number of individuals referred to Alzheimer's prevention research studies / sites

    16 years

Other Outcomes (1)

  • Total number enrolled into the Alzheimer's Prevention Registry

    16 years

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Anyone who meets entry criteria is eligible to join the Registry.

You may qualify if:

  • Must be able to accept the Alzheimer's Prevention Registry website terms and conditions

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banner Alzheimer's Institute

Phoenix, Arizona, 85006, United States

RECRUITING

Related Publications (1)

  • Langbaum JB, High N, Nichols J, Kettenhoven C, Reiman EM, Tariot PN. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies. J Prev Alzheimers Dis. 2020;7(4):242-250. doi: 10.14283/jpad.2020.31.

Related Links

MeSH Terms

Conditions

Alzheimer DiseaseDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Jessica Langbaum, PhD

    Banner Alzheimer's Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nellie High, MA

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Director, Research Strategy

Study Record Dates

First Submitted

December 23, 2013

First Posted

December 30, 2013

Study Start

May 1, 2012

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Last Updated

December 16, 2025

Record last verified: 2025-12

Locations